Versor Investments LP Increases Stock Holdings in Humana Inc. (NYSE:HUM)

Versor Investments LP increased its holdings in shares of Humana Inc. (NYSE:HUM) by 120.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,397 shares of the insurance provider’s stock after buying an additional 1,857 shares during the period. Versor Investments LP’s holdings in Humana were worth $862,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Transcend Capital Advisors LLC lifted its holdings in Humana by 399.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock valued at $924,000 after purchasing an additional 2,914 shares in the last quarter. FNY Investment Advisers LLC lifted its holdings in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after purchasing an additional 26,856 shares in the last quarter. Retirement Systems of Alabama lifted its holdings in Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after purchasing an additional 192,801 shares in the last quarter. PDT Partners LLC lifted its holdings in Humana by 190.0% in the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after purchasing an additional 2,660 shares in the last quarter. Finally, Secure Asset Management LLC purchased a new position in Humana in the 4th quarter valued at $244,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE HUM opened at $261.49 on Friday. The company has a market cap of $31.55 billion, a P/E ratio of 26.28, a P/E/G ratio of 2.05 and a beta of 0.56. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a 50-day moving average of $270.64 and a two-hundred day moving average of $287.87. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.35%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is currently 35.58%.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of research reports. StockNews.com upgraded Humana from a “hold” rating to a “buy” rating in a report on Tuesday. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Morgan Stanley cut their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Piper Sandler raised their target price on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Finally, Wells Fargo & Company cut their target price on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Nineteen equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $285.68.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.32% of the stock is currently owned by corporate insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.